Cas No.: | 239101-33-8 |
Chemical Name: | Deferitrin |
Synonyms: | Deferitrin;(2Z,4S)-2-(2-hydroxy-4-oxocyclohexa-2,5-dien-1-ylidene)-4-methyl-1,3-thiazolidine-4-carboxylic acid;4'-Hydroxydesazadesferrithiocin;GT 56-252;UNII-T69Y9LDN44;4,5-Dihydro-2-(2,4-dihydroxyphenyl)-4-methylthiazol-4-(S)-carboxylic acid |
SMILES: | O=C([C@]1(C)N=C(C2=CC=C(O)C=C2O)SC1)O |
Formula: | C11H11NO4S |
M.Wt: | 253.274 |
Purity: | >98% |
Sotrage: | 2 years -20°C Powder, 2 weeks 4°C in DMSO, 6 months -80°C in DMSO |
Description: | Deferitrin (GT-56-252), a desferrithiocin (DFT) analogue, is an orally active trident iron chelator. Deferitrin is used for chronic iron overload due to transfusional therapy. Deferitrin has the potential for beta-thalassemia major[1][2]. |
In Vitro: | The iron-clearing efficiency (ICE) of Deferitrin (GT-56-252) in a non-iron-overloaded rodent model after oral (po) administration at 300 µmol/kg is shown to be 1.1%[1]. |